摘要
目的:探讨伏立康唑治疗恶性血液病患者合并侵袭性真菌感染(IF I)的结果。方法:选择山西医科大学第二医院血液科2006年2月-2007年5月收治的恶性血液病合并IF I患者20例,采用常规剂量的伏立康唑序贯治疗。结果:20例IF I患者总治愈率和有效率分别为61.1%和83.3%。结论:恶性血液病合并侵袭性真菌感染者应用伏立康唑治疗有效,副作用小,安全性高。
Objective:To investigate the effects of voriconazole in patients with malignant hematological disorders complicated by invasive fungal infection.Methods:Twenty patients selected in the department of hematology of 2nd hospital of Shanxi medical university with malignant hematological disorders complicated by invasive fungal infection were treated by voficonazole.Results:The overall cure rate and response rate in 20 patients with IFI was 61.1%and 83.3% respectively.Conclusion:Voriconazole is effective and safe in the treatment of malignant hematological disorders complicated by invasive fungal infection.
出处
《临床医药实践》
2007年第10期977-979,共3页
Proceeding of Clinical Medicine
关键词
恶性血液病
侵袭性真菌感染
伏立康唑
malignant hematological disorders
invasive fungal infection
voriconazole
